Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-a level in patients with mucocutaneous type of Behcet's disease
- Author
- SUN, Andy1 2 ; WANG, Yi-Ping2 3 ; CHIA, Jean-San4 5 ; LIU, Bu-Yuan1 2 ; CHIANG, Chun-Pin1 2 3 4
[1] Department of Dentistry, National Taiwan University Hospital, College of Medicine, Taiwan, Province of China
[2] School of Dentistry, Notional Taiwan University, Taipei, Taiwan, Province of China
[3] Graduate Institute of Clinical Dentistry, Notional Taiwan University, Taipei, Taiwan, Province of China
[4] Graduate Institute of Oral Biology, Notional Taiwan University, Taipei, Taiwan, Province of China
[5] Graduate Institute of Microbiology, Notional Taiwan University, Taipei, Taiwan, Province of China - Source
Journal of oral pathology & medicine. 2009, Vol 38, Num 5, pp 401-405, 5 p ; ref : 42 ref
- ISSN
- 0904-2512
- Scientific domain
- Otorhinolaryngology, stomatology, dentistry
- Publisher
- Wiley, Frederiksberg
- Publication country
- Denmark
- Document type
- Article
- Language
- English
- Author keyword
- Behcet's disease interleukin-6 interleukin-8 levamisole mucocutaneous type tumour necrosis factor-α
- Keyword (fr)
- Anthelminthique Antiparasitaire Colchicine Cutanéomuqueux Homme Hypouricémiant Immunostimulant Interleukine 6 Interleukine 8 Lévamisole Maladie de Behçet Nécrose ORL Réduction Stomatologie Traitement Tumeur Maladie de système Pathologie de l'appareil circulatoire Pathologie de l'appareil génital Pathologie de l'oeil Pathologie de la peau Pathologie des vaisseaux sanguins Vascularite
- Keyword (en)
- Anthelmintic Parasiticide Colchicine Mucocutaneous Human Hypouricemic agent Immunostimulant agent Interleukin 6 Interleukin 8 Levamisole Behçet syndrome Necrosis ENT Reduction Stomatology Treatment Tumor Systemic disease Cardiovascular disease Genital diseases Eye disease Skin disease Vascular disease Vasculitis
- Keyword (es)
- Antihelmíntico Antiparasitario Colchicina Cutaneomucoso Hombre Hipouricemiante Inmunoestimulante Interleuquina 6 Interleuquina 8 Levamisol Behçet síndrome Necrosis ORL Reducción Estomatología Tratamiento Tumor Enfermedad sistémica Aparato circulatorio patología Aparato genital patología Ojo patología Piel patología Vaso sanguíneo patología Vasculitis
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S06 Antiparasitic agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B07 Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B10 Otorhinolaryngology. Stomatology
- Discipline
- Otorhinolaryngology. Stomatology Pharmacological treatments Sarcoidosis. Granulomatosis of undetermined origin. Connective tissue diseases. Vasculitides
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21399379
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1600-0714.2009.00774.x 
https://dx.doi.org/10.1111/j.1600-0714.2009.00774.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0714.2009.00774.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:163:\"Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-a level in patients with mucocutaneous type of Behcet's disease\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of oral pathology & medicine\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. oral pathol. med\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"401\";s:8:\"\u0000*\u0000epage\";s:3:\"405\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0904-2512\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"SUN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Andy\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:13:\"WANG, Yi-Ping\";i:1;s:14:\"CHIA, Jean-San\";i:2;s:12:\"LIU, Bu-Yuan\";i:3;s:16:\"CHIANG, Chun-Pin\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:163:\"Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-a level in patients with mucocutaneous type of Behcet's disease\";s:8:\"\u0000*\u0000place\";s:13:\"Frederiksberg\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0714.2009.00774.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:163:\"Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-a level in patients with mucocutaneous type of Behcet's disease\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of oral pathology & medicine\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. oral pathol. med\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"401\";s:8:\"\u0000*\u0000epage\";s:3:\"405\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0904-2512\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"SUN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Andy\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:13:\"WANG, Yi-Ping\";i:1;s:14:\"CHIA, Jean-San\";i:2;s:12:\"LIU, Bu-Yuan\";i:3;s:16:\"CHIANG, Chun-Pin\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:163:\"Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-a level in patients with mucocutaneous type of Behcet's disease\";s:8:\"\u0000*\u0000place\";s:13:\"Frederiksberg\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0714.2009.00774.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0714.2009.00774.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:163:\"Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-a level in patients with mucocutaneous type of Behcet's disease\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of oral pathology & medicine\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. oral pathol. med\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"401\";s:8:\"\u0000*\u0000epage\";s:3:\"405\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0904-2512\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"SUN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Andy\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:13:\"WANG, Yi-Ping\";i:1;s:14:\"CHIA, Jean-San\";i:2;s:12:\"LIU, Bu-Yuan\";i:3;s:16:\"CHIANG, Chun-Pin\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:163:\"Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-a level in patients with mucocutaneous type of Behcet's disease\";s:8:\"\u0000*\u0000place\";s:13:\"Frederiksberg\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0714.2009.00774.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:163:\"Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-a level in patients with mucocutaneous type of Behcet's disease\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Journal of oral pathology & medicine\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. oral pathol. med\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"38\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"401\";s:8:\"\u0000*\u0000epage\";s:3:\"405\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0904-2512\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:3:\"SUN\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Andy\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:13:\"WANG, Yi-Ping\";i:1;s:14:\"CHIA, Jean-San\";i:2;s:12:\"LIU, Bu-Yuan\";i:3;s:16:\"CHIANG, Chun-Pin\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:163:\"Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-a level in patients with mucocutaneous type of Behcet's disease\";s:8:\"\u0000*\u0000place\";s:13:\"Frederiksberg\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
